Trials / Completed
CompletedNCT01122563
A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment
Reproducibility Study of OABSS and Its Response to Treatment in Indonesia - Part 2: Responsiveness
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate change of overactive bladder symptom scores (OABSS) between, before and after solifenacin treatment to OAB subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Solifenacin | oral |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2010-05-13
- Last updated
- 2011-01-13
Locations
3 sites across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT01122563. Inclusion in this directory is not an endorsement.